CD34+ EPCs isolated from human peripheral blood have also been shown to be of potential therapeutic use in myocardium infarction rat models by contributing to the post-infarction neovascularization and aiding to improve the associated symptoms (Shintani et al., 2006). This evidence concerns the gene CD34 and infarction.